185 filings
Page 6 of 10
UPLOAD
v3jttrcymogm s51r
14 Feb 23
Letter from SEC
12:00am
CORRESP
nzjhjbt4pln w6amdbc
9 Feb 23
Correspondence with SEC
12:00am
UPLOAD
u8g7st iejwl9q1
8 Feb 23
Letter from SEC
12:00am
S-4/A
dybi7tege fs
27 Jan 23
Registration of securities issued in business combination transactions (amended)
6:02pm
CORRESP
re4mh sca2k8y9
27 Jan 23
Correspondence with SEC
12:00am
UPLOAD
6wxrs ccrkm7smaxd
19 Jan 23
Letter from SEC
12:00am
425
urs3cz ehaxxx
11 Jan 23
Business combination disclosure
8:30am
8-K
dyn g17o6mm83h
11 Jan 23
Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event
8:30am
8-K
vosc xos09
29 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
S-4
xk2 crhy9
23 Dec 22
Registration of securities issued in business combination transactions
6:06am
8-K
30zydfb9dqm 4r2
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
2ev w8aymtq16v89d
3 Nov 22
Vallon Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:32pm
8-K
q04viamjva 0wh
28 Jul 22
Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:04am
8-K
jhww0hd en
26 Jul 22
Entry into a Material Definitive Agreement
4:12pm
8-K
7jn4fqmt wnm1k8mh
13 Jul 22
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
vrj56
28 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm